Breaking News Instant updates and real-time market news.

NVO

Novo Nordisk

$56.41

1.14 (2.06%)

04:55
11/04/19
11/04
04:55
11/04/19
04:55

Novo Nordisk management to meet with JPMorgan

Meeting to be held in Boston on November 4 hosted by JPMorgan.

  • 04

    Nov

  • 07

    Dec

NVO Novo Nordisk
$56.41

1.14 (2.06%)

08/30/19
JEFF
08/30/19
DOWNGRADE
JEFF
Underperform
Novo Nordisk downgraded to Underperform from Hold at Jefferies
Jefferies analyst Peter Welford downgraded Novo Nordisk to Underperform from Hold while raising his price target for the shares to DKK 300 from DKK 295. The analyst believes the shares at current levels are becoming expensive. Approval of oral semaglutide is imminent in the U.S., but pricing could drive below-average margins, Welford tells investors in a research note.
08/30/19
08/30/19
DOWNGRADE

Fly Intel: Top analyst downgrade
Catch up on today's top analyst downgrades with this list compiled by The Fly: 1. Ulta Beauty (ULTA) downgraded to Neutral from Buy at Citi, to Neutral from Overweight at Piper Jaffray and Atlantic Equities, to Neutral from Outperform at Exane BNP Paribas, to Market Perform from Outperform at Wells Fargo, and to Equal Weight from Overweight at Morgan Stanley. 2. Toronto-Dominion (TD) downgraded to Market Perform from Outperform at BMO Capital with analyst Sohrab Movahedi saying he views the company's Q4 results as a "low-quality meet" and believes the stock's total return potential is now in line with other similarly rated banks. 3. Novo Nordisk (NVO) downgraded to Underperform from Hold at Jefferies with analyst Peter Welford saying he believes the shares at current levels are becoming expensive. 4. UBS (UBS) downgraded to Neutral from Outperform at Exane BNP Paribas. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/17/19
SBSH
09/17/19
UPGRADE
SBSH
Buy
Novo Nordisk upgraded to Buy from Neutral at Citi
Citi analyst Peter Verdult upgraded Novo Nordisk to Buy from Neutral and raised his price target for the shares to DKK 415 from DKK 334. The analyst believes the company's GLP-1 franchise across diabetes, obesity and nonalcoholic steatohepatitis is "burgeoning." His survey of doctors suggests the company's volume penetration in diabetes could reach 25%-35% versus 7% now. Verdult boosted his earnings estimates for Novo through 2024 up to 20% ahead of consensus expectations.
10/09/19
STFL
10/09/19
NO CHANGE
STFL
Hold
Bluebird Hem A collaboration not stock moving, but worth monitoring, says Stifel
Stifel analyst Benjamin Burnett said he does not expect news that Blubird Bio (BLUE) is entering the Hemophila A race via a collaboration with Novo Nordisk (NVO) to be stock moving, but he does think it is "certainly worth monitoring." Biomarin's (BMRN) gene therapy candidate Valrox sets "the bar for genetic medicines in heme A today," said Burnett, who noted that gene therapies from Spark (ONCE) and Pfizer (PFE) are also in the clinic. However, "there does appear to be room for efficacy improvement as none of the clinical data generated from genetic medicines to date is a clear home run," Burnett added in his note to investors. He keeps a Hold rating on Bluebird Bio shares.

TODAY'S FREE FLY STORIES

FEYE

FireEye

$16.37

0.095 (0.58%)

16:13
12/09/19
12/09
16:13
12/09/19
16:13
Downgrade
FireEye rating change  »

FireEye assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 08

    Jan

MTN

Vail Resorts

$231.30

-1.43 (-0.61%)

16:13
12/09/19
12/09
16:13
12/09/19
16:13
Hot Stocks
Vail Resorts announces key capital investments for 2020/21 N American ski season »

Vail Resorts announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CHWY

Chewy

$24.13

-0.8 (-3.21%)

16:13
12/09/19
12/09
16:13
12/09/19
16:13
Earnings
Chewy reports Q3 EPS (20c), consensus (16c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

SFIX

Stitch Fix

$25.11

0.98 (4.06%)

16:12
12/09/19
12/09
16:12
12/09/19
16:12
Earnings
Stitch Fix reports Q1 EPS breakeven, consensus (6c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

  • 12

    Dec

  • 19

    Dec

MCK

McKesson

$143.11

0.79 (0.56%)

16:12
12/09/19
12/09
16:12
12/09/19
16:12
Hot Stocks
McKesson names Nancy Flores chief information and chief technology officer »

McKesson Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTE

Astec

$38.12

-0.68 (-1.75%)

16:12
12/09/19
12/09
16:12
12/09/19
16:12
Hot Stocks
Astec to sell GEFCO subsidiary »

Astec Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

PHR

Phreesia

$29.03

-0.07 (-0.24%)

16:12
12/09/19
12/09
16:12
12/09/19
16:12
Earnings
Phreesia raises FY20 revenue view to $122M-$122.5M from $118.5M-$119M »

Consensus $118.9M. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PSN

Parsons

$40.16

-0.3 (-0.74%)

16:11
12/09/19
12/09
16:11
12/09/19
16:11
Hot Stocks
Parsons wins prime position on $7.5B defense information technology contract »

Parsons has won a prime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

EQ

Equillium

$4.00

-0.03 (-0.74%)

16:11
12/09/19
12/09
16:11
12/09/19
16:11
Hot Stocks
Equillium says FDA granted Fast Track designation for itolizumab »

Equillium announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHR

Phreesia

$29.03

-0.07 (-0.24%)

16:11
12/09/19
12/09
16:11
12/09/19
16:11
Earnings
Phreesia reports Q3 EPS (7c), consensus (8c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

RPD

Rapid7

$53.18

-0.88 (-1.63%)

16:10
12/09/19
12/09
16:10
12/09/19
16:10
Initiation
Rapid7 initiated  »

Rapid7 initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

APTX

Aptinyx

$4.18

0.06 (1.46%)

16:10
12/09/19
12/09
16:10
12/09/19
16:10
Hot Stocks
Aptinyx presents preclinical NYX-783 data at Neuropsychopharmacology meeting »

Aptinyx announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$55.30

0.48 (0.88%)

, SAP

SAP

$134.82

-0.13 (-0.10%)

16:10
12/09/19
12/09
16:10
12/09/19
16:10
Hot Stocks
Oracle names Dr. Vishal Sikka to board of directors »

Oracle (ORCL) announced…

ORCL

Oracle

$55.30

0.48 (0.88%)

SAP

SAP

$134.82

-0.13 (-0.10%)

INFY

Infosys

$9.95

0.01 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

SUPN

Supernus

$22.72

-0.115 (-0.50%)

16:10
12/09/19
12/09
16:10
12/09/19
16:10
Hot Stocks
Breaking Hot Stocks news story on Supernus »

Supernus trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHP

Ryman Hospitality

$89.29

-0.59 (-0.66%)

, STRS

Stratus Properties

$27.85

(0.00%)

16:09
12/09/19
12/09
16:09
12/09/19
16:09
Hot Stocks
Ryman Hospitality to acquire Block 21 from Stratus Properties »

Ryman Hospitality…

RHP

Ryman Hospitality

$89.29

-0.59 (-0.66%)

STRS

Stratus Properties

$27.85

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$49.36

-1.53 (-3.01%)

16:09
12/09/19
12/09
16:09
12/09/19
16:09
Initiation
Crowdstrike initiated  »

Crowdstrike assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 09

    Dec

MDB

MongoDB

$131.03

-0.19 (-0.14%)

16:08
12/09/19
12/09
16:08
12/09/19
16:08
Hot Stocks
MongoDB CEO calls Q3 results 'terrific' »

"MongoDB's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 18

    Dec

KZR

Kezar Life Sciences

$2.72

0.07 (2.64%)

16:08
12/09/19
12/09
16:08
12/09/19
16:08
Hot Stocks
Kezar Life Sciences highlights potential of protein secretion inhibitors at ASH »

Kezar Life Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESEA

Euroseas

$0.48

0.0485 (11.29%)

16:08
12/09/19
12/09
16:08
12/09/19
16:08
Hot Stocks
Euroseas announces 1-for-8 reverse stock split »

Euroseas Ltd. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFRX

ContraFect

$0.30

-0.0373 (-11.20%)

, PFE

Pfizer

$38.33

0.035 (0.09%)

16:07
12/09/19
12/09
16:07
12/09/19
16:07
Syndicate
ContraFect announces common stock offering, private placement to Pfizer »

ContraFect announced that…

CFRX

ContraFect

$0.30

-0.0373 (-11.20%)

PFE

Pfizer

$38.33

0.035 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

STRS

Stratus Properties

$27.85

(0.00%)

16:07
12/09/19
12/09
16:07
12/09/19
16:07
Hot Stocks
Stratus Properties to sell Block 21 to Ryman Hospitality Properties for $275M »

Stratus Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDB

MongoDB

$130.89

-0.33 (-0.25%)

16:07
12/09/19
12/09
16:07
12/09/19
16:07
Earnings
MongoDB sees FY20 adjusted EPS ($1.04)-($1.02), consensus ($1.07) »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 18

    Dec

NDLS

Noodles & Company

$5.80

(0.00%)

16:07
12/09/19
12/09
16:07
12/09/19
16:07
Hot Stocks
Noodles & Company appoints Stacy Pool Chief Marketing Officer »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAKE

Lakeland Industries

$10.05

-0.1 (-0.99%)

16:06
12/09/19
12/09
16:06
12/09/19
16:06
Earnings
Lakeland Industries reports Q3 EPS 14c, two estimates 14c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

MDB

MongoDB

$130.89

-0.33 (-0.25%)

16:06
12/09/19
12/09
16:06
12/09/19
16:06
Earnings
MongoDB sees Q4 adjusted EPS (29c)-(27c), consensus (30c) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.